Supplemental Table 1. Mus musculus specific primer sequences used for qRT-PCR analyses

Gene Primer Sequence
Bmp2-
Hoxa10-
Hoxa10- 
SUPPLEMENTAL EXPERIMENTAL PROCEDRES Mice
Virgin BPH/5 and control C57Bl/6 (C57) mice (8-12 weeks old) were obtained from in-house colonies. It should be noted that C57 was one of the original strains from which BPH/5 was derived and is used as a control in studies of BPH/5 (1) . Strain-matched and inter-strain matings (reciprocal crosses) were performed with BPH/5 and C57 to induce pregnancy. The day of vaginal plug detection is defined as e0.5. Celecoxib (Sigma Aldrich, St. Louis, MO) was administered to pregnant mice one time at e6.5 by oral gavage at a dose of 10 mg/kg body weight (dissolved in 100uL sesame oil), a dosage tested safe during early rodent pregnancy (2) . For analysis of pregnancy outcomes, C57 and BPH/5 pregnant females treated with vehicle (sesame oil) or celecoxib at e6.5 were euthanized at e10.5, e12.5, or e18.5. Uterine horns were exposed and litter size was counted. Placentae and fetuses were dissected free from the gestational sac and weights were recorded. Resorptions were visualized by ultrasound and/or lack of a fetus within a gestational sac. Care of the mice met or exceeded the standards set forth by the National Institutes of Health Guide for the Care and Use of Laboratory Animals, USDA regulations, and the AVMA Panel on Euthanasia.
Pontamine blue perfusion studies
Pregnant females at e3.5pm (20 00h), e4.5am (8 00h), e4.5pm (20 00h), or e5.5am (8 00h) were given a single tail vein injection of 1% pontamine blue (BDH, Radnor, PA) dissolved in saline (100µL), and were euthanized after 5 minutes. Distinct blue bands (implantation sites) were collected. The incidence of embryo clustering was recorded and defined as an implantation site that is located less than the length of one implantation site (~1mm) away from an adjacent implantation site.
Embryo recovery and in vitro staging
To evaluate pre-implantation embryo development, BPH/5 and C57 gravid uteri were flushed on the morning of e3.5 from intra-and/or inter-strain crosses. Embryos were washed with M2 embryo-holding medium (Sigma Aldrich, St. Louis, MO) and staged (ie morula or blastocyst) using a dissecting microscope (Carl Zeiss, Oberkochen, Germany) according to published protocols (3).
Alkaline phosphatase activity assay
To assess decidualization of uterine tissues, alkaline phosphatase (ALP) activity assays were performed in BPH/5 and C57 implantation sites at e4.5am, e4.5pm, or e5.5am as described (4) . Uteri with implantation sites were fixed in 4% paraformaldehyde (PFA) overnight at 4°C followed by sucrose gradients in PBS (15 and 30%) and frozen in embedding medium OCT. Frozen tissue was sectioned (16 μm) and mounted on poly-L-lysine-coated slides. Slides were post-fixed in 0.2% glutaraldehyde, washed in PBS, and incubated with a 100 mM Tris buffer (pH 9.5) containing chromogenic substrates for ALP (168.5 µL of 100mg/mL nitro blue tetrazolium salt in dimethylformamide and 175 µL of 50 mg/mL 5-bromo-4-chloro-3-indoyl phosphate/toluidinium salt in dimethylformamide added to 50 mL of Tris buffer; Roche, Penzburg, Germany). The development of a purple color is indicative of ALP activity. Quantification of ALP activity, with purple staining corresponding to the area of decidualization, was performed using the average of 3 adjacent sections from ≥3 implantation sites per time point. All measurements were made using Image J software (NIH).
Ultrasound assessment of fetoplacental health
Pregnant C57 and BPH/5 mice from intra-strain matings were anesthetized using 2% isofluorane. A Vevo 770 ultra-high frequency ultrasound (Visualsonics, Toronto, ON) was used to examine fetal health at e10.5. A ventral incision was made to exteriorize the uterus and examine individual implantation sites using a 40MHz probe according to published methods (5) . Body temperature of the pregnant females was maintained and monitored throughout the recording procedure. Fetal heart rates (HR) were measured and reported as a ratio of fetal heart rate to maternal heart rate (HR ratio) to control for minor variations in anesthesia. Fetal crown rump lengths (CRL) were recorded when orientation permitted (6) . BPH/5 fetuses that had similar HR ratios as C57 were classified as healthy, while BPH/5 fetuses that had significantly lower HR ratios and reduced CRLs compared to C57 were considered compromised (Supplementary Table  2 ). Resorptions were classified by the lack of a fetus within a gestational sac and/or a fetal heart.
Quantitative Real-time PCR
Primers were designed using Primer Design software provided by Integrative DNA Technologies (www.idtdna.com). Total RNA was extracted using TriZol (Life Technologies, Grand Island, NY) as previously described (7) . Reverse transcription was performed using Quanta kits (Gaithersburg, MD) per the manufacturer's instructions, and quantitative real-time PCR (qRT-PCR) was performed with 25ng cDNA in triplicate using SybrGreen reagents (Quanta) on an ABI 7500 Fast System (Applied Biosystems, Life Technologies, Grand Island, NY). Data was expressed as 2^-dCt relative to housekeeper gene expression (18S rRNA). Primer sequences can be found in Supplementary Table 1 .
In situ hybridization
In situ hybridization (ISH) was performed as previously described (8) . Implantation sites were collected and snap frozen. Tissue sections (12 μm) were mounted on poly-L-lysine coated slides, fixed in 4% PFA solution in PBS at 4°C and acetylated. After pre-hybridization, sections were hybridized at 45°C for 4 hours in 50% formamide buffer containing 35 S-labeled sense or antisense cRNA probes. After hybridization, RNase A-resistant hybrids were detected by autoradiography using Kodak NTB-2 liquid emulsion. Parallel sections were hybridized with sense probes and served as negative controls.
